Therapy Areas
8 January 2026 - Saluda Medical, Inc. (ASX: SLD), an American commercial-stage medical device company, said on Thursday that its next-generation EVA Sensing Technology has received CE certification for commercialisation in Europe, with recognition of...
8 January 2026 - US healthcare company Organon (NYSE:OGN) announced on Thursday that it has entered into a commercialisation agreement with Daiichi Sankyo Europe to distribute and promote Nilemdo in France, Denmark, Iceland, Sweden, Finland, and Norw...
8 January 2026 - Private equity firm Antin Infrastructure Partners (Euronext Paris:ANTIN) announced on Thursday that it has agreed to acquire Emsere from Dutch family investment platform Gryphion.Emsere, headquartered in Leiden in the Netherlands, is...
8 January 2026 - Arbele, a Hong Kong-based biotechnology company focused on developing innovative targeted cancer therapies, announced on Wednesday that it has received Orphan Drug Designation (ODD) from the US Food and Drug Administration (FDA) for ...
8 January 2026 - Pharmaceutical company Eli Lilly and Company (NYSE:LLY) announced on Wednesday that it has signed a definitive agreement to acquire Ventyx Biosciences Inc (Nasdaq:VTYX), a clinical-stage biopharmaceutical company focused on developin...
7 January 2026 - US pharmaceutical company Merck & Co Inc (NYSE:MRK), known as MSD outside the US and Canada, confirmed on Wednesday that it has completed its cash tender offer for all outstanding shares of Cidara Therapeutics Inc (Nasdaq:CDTX), ...
7 January 2026 - Biopharmaceutical company GSK plc (LSE: GSK) (NYSE: GSK) announced on Wednesday that the European Commission has approved a prefilled syringe presentation of its shingles vaccine Shingrix, providing a simplified administration option...